Purine nucleotides and their metabolites in erythrocytes of streptozotocin diabetic rats

Diabetes and Metabolism

Volumn 30, Issue 6, 2004, Pages 557-567

  Dudzinska, W ^a   Hlynczak, A J ^a  

^a UNIVERSITY OF SZCZECIN   (Poland)

Author keywords

ATPase; HPLC; Purine and pyridine nucleotides; Streptozotocin diabetic rats

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; GUANINE NUCLEOTIDE; GUANOSINE; GUANOSINE DIPHOSPHATE; GUANOSINE PHOSPHATE; GUANOSINE TRIPHOSPHATE; HYPOXANTHINE; INOSINE; INOSINE PHOSPHATE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NUCLEOSIDE; PURINE NUCLEOTIDE; PYRIDINE NUCLEOTIDE; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPHOSPHORYLATION; DIABETES MELLITUS; ENERGY TRANSFER; ENZYME ACTIVITY; ERYTHROCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLITE; NONHUMAN; NUCLEOTIDE METABOLISM; PURINE METABOLISM; RAT; STREPTOZOCIN DIABETES;

EID: 11244327795     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70155-6     Document Type: Article

References (64)

1. Haring HU. The insulin receptor: signaling mechanism and contribution to the pathogenesis of insulin resistance. Diabetologia, 1991, 34, 848-61.
2. Moller DE, Flier JS. Insulin resistance-mechanism, syndromes, and implications. N Engl J Med, 1991, 325, 938-48.
3. Becker MA, Meyer LJ, Huisman WH, Lazar C, Adams MB. Human erythrocyte phosphoribosylphosphate synthetase. Subunit analysis and states of subunit association. J Biol Chem, 1977, 252, 3911-8.
4. Meyer LJ, Becker MA. Human erythrocyte phosphoribosylphosphate synthetase. J Biol Chem, 1977, 252, 3919-25.
5. Bontemps F, Van den Berghe G, Hers G. Pathways of adenine nucleotide catabolism in erythrocytes. J Clin Invest, 1986, 77, 824-30.
6. Simmonds HA, Fairbank LD, Morris GS, Webster DR, Harley EH. Altered erythrocyte nucleotide patterns are characteristic of inherited disorder of purine or pyrimidine metabolism. Clin Chim Acta, 1988, 171, 197-210.
7. Smolenski RT, Montero C, Duley JA, Simmonds HA. Effects of adenosine analogues on ATP concentrations in human erythrocytes. Biochem Pharmacol, 1991, 42, 1767-73.
8. Crespillo J, Llorente P, Argomaniz L, Montero C. APRT from erythrocytes of HGPRT deficient patiens: Kinetic, regulatory and thermo stability properties. Mol Cell Biochem, 2003, 254, 359-63.
9. Ataullakhanov FI, Vitvitsky VM, Komarova SV. Energy dependent processes and adenylate metabolism in human erythrocytes. Biochemistry (Moscow). 1996, 61, 197-203.
10. Komarova S, Mosharov EV, Vitvitski V, Ataullakhanov FI. Adenine nucleotide synthesis in human erythrocytes depends on the mode of supplementation of cell suspension with adenosine. Blood Cell, 1999, 25, 170-9.
11. Ataullakhanov FJ, Vitvitsky VM. What determines the intracellular ATP concentration. Bioscence Reports, 2002, 22, 501-11.
12. Bontemps F, Van den Berghe G, Hers G. 5′-nucleotidase activities in human erythrocytes: identification of a purine 5′-nucleotidase stimulated by ATP and glycerate 2,3-bisphosphate. Biochem J, 1988, 250, 687-96.
13. Sala-Newby GB, Skladonowski AC, Newby AC. The mechanism of adenosine formation in cells. J Biol Chem, 1999, 274, 17789-93.
14. Amici A, Magini G. Human erythrocyte 5′-nucleotidase, PN-I. Arch Biochem Biophys, 2002, 397, 184-90.
15. Baldini P, Incerpi S, Pascale E, Verna R, Lully P. Insulin effects on human red blood cells. Mol Cell Endocrinol, 1986, 46, 93-102.
16. Jamal Z, Saggerson ED. Enzymes involved in Ado metabolism in rat white and brown adipocytes. Effects of streptozotocin-diabetes, hypothyroidism, age and sex differences. Biochem J, 1987, 245, 881-6.
17. Jenkins RL, Daniel MC, Digernes S, Parris SW, Ong RL. Adenine nucleotide metabolism in hearts of diabetic rats. Comparison to diaphragm, liver and kidney. Diabetes, 1988, 37, 629-36.
18. Hoshino T, Yamada K, Masuoka K, et al. Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract, 1994, 25, 97-102.
19. Sakowicz M, Pawelczyk T. Insulin restores expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats. Mol Cell Biochem, 2002, 236, 163-71.
20. Donacelli M, Russo V, Bucalo ML, et al. Increase in red cell lactate concentration and its reduction by isologus plasma in NIDDM subjects. Diabetes Res, 1990, 15, 33-5.
21. Donatelli M, Russo V, Bucalo ML, Scarpinato A, Iraci T. Erythrocyte glucose, ATP, lactate concentration and their modifications induced by isologues plasma in non-insulin-dependent diabetes mellitus. Diabetes Res, 1991, 16, 121-5.
22. Petruzzi E, Orlando C, Pinzani P, Sestini R, Rosso AD, Dini G. Adenosine triphosphate release by osmotic shok and hemoglobin A1C in diabetic subjects' erythrocytes. Biochemistry, 1994, 4, 435-40.
23. Suhail M, Rizvi S. Effect of type I diabetes mellitus on key glycolicic enzymes of red blood cells. Acta Diabetol Lat, 1989, 26, 315-20.
24. Bettini D, Kloting I, Kohner KD. Alterations in erythrocyte plasma membrane ATPase activity and adenine nucleotide content in spontaneously diabetic sub line of the Chinese hamster. Horm Metab Res, 1996, 28, 1-6.
25. Rabini RA, Fumelli P, Staffolani R, et al. Effects of diabetes mellitus on structural and functional properties of erythocyte membranes. Membr Biochem, 1993, 10, 71-9.
26. Rabini RA, Petruzzi E, Staffolani R, Tesei M, Fumelli M, Pazagli M. Diabetes mellitus and subjects' ageing: a study on the ATP content and ATP-related enzyme activities in human erythrocytes. Eur J Clin Invest, 1997, 27, 327-32.
27. Garner MH. Changes in Na, K-ATPase concentration and Na, K-ATPase dependent adenosine triphosphate turnover in human erythrocytes in diabetes. Metabolism, 1996, 45, 927-34.
28. Smolenski RT, Lachno DR, Ledingham SJM, Yacoub MH. Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in heart for transplantation. J Chromatogr, 1990, 527, 414-20.
29. Cha YN, Shin BC, Lee KC. Active uptake of Ca+2 and Ca+2- activated Mg+2 ATPase in red cell membrane fragments. J Gen Physiol, 1971, 57, 202-8.
30. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement Folin with the fend reagent. J Biol Chem, 1951, 193, 256-67.
31. Choi SJ, Taylor MA, Abrams R. Depression, ECT, and erythrocyte adenosinotriphosphate activity. Biol Psych, 1977, 12, 75-81.
32. Goldberg H, Fernander A. Simplified method for the estimation of inorganic phosphorus in body fluids. Clin Chem, 1966, 12, 871-5.
33. Ackerman MD, Leibman KC. Effect of experimental diabetes on drug metabolism in the rat. Drug Met Disp, 1977, 5, 405-10.
34. Agarwal MK. Streptozotocin; mechanism of action. FEBS Lett, 1980, 120, 1-3.
35. Mordes JP, Rossini AA. Animal models of diabetes. Am J Med, 1981, 70, 353-60.
36. Skett P, Joels LA. Different efects of acute and chronic diabetes mellitus on hepatic drug metabolism in the rats. Biochem Pharmacol, 1985, 34, 287-9.
37. Tegos C, Beutler E. Red cell glycolitic intermediates in diabetic patients. J Lab Clin Med, 1980, 96, 85-90.
38. Scionti I, Puxeddu A, Calabresse G, et al. Erythrocyte concentration of glycolitic phosphorylated intermediates and adenosine nucleotides in subjects with diabetes mellitus. Hor Met Res, 1982, 14, 233-6.
39. Gauchie P, Vertongen F, Bosson D, Dorchy H. Erythrocyte metabolism alteration in type I diabetes: relationship to metabolic control. Ann Biol Clin, 1992, 50, 9-13.
40. Raccah D, Lamotte M, Issautier P, Vague AP. Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripherial nerve and kidney. Diabetes Metab, 1994, 20, 271-4.
41. Raccah D, Fabreguettes C, Azulay JP, Vague P. Erythrocyte Na+,K+-ATPase activity, metabolic control, and neuropathy in 1DDM patients. Diabetes Care, 1996, 19, 564-8.
42. Kowluru RM, Berensky A, Kowluru M, Dembo PA, Keaton A, Buican T. Reversible sodium pump defect and swelling in the diabetic rat erythrocyte. Proc Natl Acad Sci USA, 1989, 86, 3327-31.
43. Colclasure CG, Parker JC. ATP dependence of K-Cl co transport in clog red blood cells. Am J Physiol, 1993, 34, 1648-52.
44. Eto M, Watanable K, Sekiguchi M, Iwashima Y, Ishii K. Metabolic and morphological changes of the heart in Chinese hamster with spontaneous long-term diabetes. Diabetes Res, 1987, 3, 297-305.
45. Sitzman FC. Erythrocyte metabolism in type I diabetes mellitus. Padriat Padol, 1984, 19, 303-9.
46. Holzhütler HG, Jacobasch G, Bisdost A. Mathematical modeling of metabolic pathways affected by an enzyme deficiency. Eur J Biochem, 1985, 149, 101-11.
47. Zerez CR, Tanaka KR. Impaired nicotinamide adenine dinudeotide synthesis in pyruvate kinase deficient human erythrocytes. A mechanism for decreased total NAD content and possible secondary cause of hemolysis. Blood, 1987, 69, 999-1005.
48. Dabrowska A. Red cell pyruvate kinase maybe control of oxygen delivery from erythrocyte. Post Hig Med Dosw, 1997, 51, 305-18.
49. Webster JM, Heseltine L, Taylor R. In vitro effect of adenosine agonist GR79236 on the insulin sensitivity of glucose utilization in rat soleus and human rectus abdominus muscle. Biochim Biophys Acta 1996, 1316, 109-13.
50. Pawelczyk T, Sakowicz M, Szczepanska-Konkel M, Angielski S. Decreased expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats. Arch Biochem Biophys, 2000, 375, 1-7.
51. Pawelczyk T, Podgorska M, Sakowicz M. The effect of insulin on expression level of nucleoside transportes in diabetic rats. Mol Pharmacol, 2003, 63, 81-8.
52. Plageman PG, Wohlhueter RM, Kraupp M. Adenosine uptake, transport, and metabolism in human erythrocytes. J Cell Physiol, 1985, 125, 330-5.
53. Kim HD. Is adenosine a second metabolic substrate for human red blood cells. Biochim Biophys Acta, 1990, 1036, 113-20.
54. Rutkiewicz J, Gorski J. On the role of insulin in regulation of adenosine deaminase activity in rat tissue. FEBS Lett, 1990, 271, 79-80.
55. Valentine WN, Paglia DE, Tartaglia AP, Glisans F. Hereditary hemolytic anemia with increased red cell adenosine deaminase and decreased adenosine triphosphate. Science, 1977, 195, 783-5.
56. Siaw MFE, Mitchell BS, Koller CA, Coleman M, Hutton JJ. ATP depletion as a consequences of adenosine deaminase inhibition in man. Proc Natl Acad Sci USA, 1980, 77, 6157-61.
57. Tavazzi B, Di Piero D, Amorini AM, et al. Energy metabolism and lipid peroxidation of human erythrocytes as function of increased oxidative stress. Eur J Biochem, 2000, 267, 684-9.
58. Tavazzi B, Amorisie AM, Fazino G, et al. Oxidative stress induces impairment of human erythrocyte energy metabolism through the oxygen radical-mediated direct activation of AMP-deammase. J Biol Chem, 2001, 276, 48083-92.
59. Wahlberg G, Adamson U, Svensson J. Pyridine nucleotides in glucose metabolism and diabetes: a review. Diabetes Met Res Rev, 2000, 16, 33-42.
60. Velikij NN, Obrosova IG, Efimov AS, Babicheva EI, Sokil OP. Nicotinamide coenzymes in the regulation of cellular metabolism in various types of diabetes. Vopr Med Khim, 1992, 38, 4502.
61. Clock G, Mc Lean P. Effects of hormones on levels of oxidized and reduced diphosphopyridine nucleotide and triphosphopyroidine nucleotide in the liver and diaphragm. Biochem J, 1955, 61, 397-402.
62. Song H, Han X, Yuon H, Rang T, Wu H. Activites of aldolase reductase, ATPase, and nucleotide concentrations of erythrocytes in patients with type 2 (non-insulin-dependent) diabetes mellitus. Chinese Med J, 1991, 104, 818-24.
63. Bravi MC, Pietrageli P, Laurenti O, et al. Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. Metabolism, 1997, 46, 1194-8.
64. Grunewald RW, Weber I, Kinne RK. Control of sorbitol metabolism in renal inner medulla of diabetic rats. Biochim Biophys Acta, 1993, 1225, 39-47.